MedTrace Logo

Evaluation of the Prevalence of Persistent Pulmonary Hypertension in Neonates

NCT03499418 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2022-10-04

No results posted yet for this study

Summary

Transient Tachypnea of the Newborn (TTN) is one of the common causes of neonatal respiratory distress as a result of delayed clearance of fetal lung fluid.

Neonates with TTN usually require noninvasive respiratory support (e.g. nasal cannula, nasal CPAP) and may need supplemental oxygen therapy to maintain normal oxygen saturation levels. There have also been reports of "malignant TTN," in which affected children develop persistent pulmonary hypertension of the newborn (PPHN).

Conditions

  • Transient Tachypnea of the Newborn
  • PPHN

Interventions

OTHER

modified Silverman scale

Clinical assessment of severity of respiratory failure

DIAGNOSTIC_TEST

echocardiography

echocardiographic evaluation of haemodynamic problems

Sponsors & Collaborators

  • Princess Anna Mazowiecka Hospital, Warsaw, Poland

    lead OTHER

Principal Investigators

  • Maria K. Borszewska-Kornacka, MD, ProfTit · Medical University of Warsaw

Eligibility

Min Age
10 Minutes
Max Age
6 Hours
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2023-03-31
Completion
2024-09-30

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03499418 on ClinicalTrials.gov